Evli Yrityslaina vs UBS Lux Equity Fund Biotech USD

Evli Yrityslaina vs UBS Lux Equity Fund Biotech USD

1. Evli Yrityslaina

  • Security

    Evli Corporate Bond B

  • Fee

    0.97%

  • ISIN

    FI0008801097

  • Holdings

    17

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    9

Fund Holdings

We have information about 17 holdings in Evli Yrityslaina, where the largest holding is Societe Generale (1.81), followed by Eurogrid (1.43) and Redeia (1.22). In comparison with UBS Lux Equity Fund Biotech USD, we have 11 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Moderna (9.21) and Vertex (8.44).

All Holdings

Here we compare the holdings in Evli Yrityslaina and UBS Lux Equity Fund Biotech USD.

Evli Yrityslaina UBS Lux Equity Fund Biotech USD
1. Societe Generale SA
France
1.81 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Eurogrid GmbH
Germany
1.43 %
2. Moderna Inc
9.21 %
3. Redeia Corporacion SA
Spain
1.22 %
3. Vertex Pharmaceuticals Inc
8.44 %
4. Mölnlycke Holding AB
Sweden
1.14 %
4. Alnylam Pharmaceuticals Inc
8.08 %
5. Statnett SF
Norway
1.1 %
5. AbbVie Inc
USA
4.91 %
6. Telenor ASA
Norway
1.08 %
6. Gilead Sciences Inc
USA
4.66 %
7. Ellevio AB
Sweden
1.08 %
7. Amgen Inc
USA
4.43 %
8. BNP Paribas SA
France
1.06 %
8. BioNTech SE
4.13 %
9. Loomis B
Sweden
0.97 %
9. Karuna Therapeutics Inc
3.75 %
10. Akelius Residential Property Finance BV
0.97 %
-
11. Siemens Financieringsmaatschappij NV
Netherlands
0.97 %
-
12. Allianz SE
Germany
0.96 %
-
13. SpareBank 1 Sør-Norge ASA
Norway
0.96 %
-
14. TenneT Holding BV
Netherlands
0.94 %
-
15. NTI Group Holding ApS
Denmark
0.88 %
-
16. Kojamo Oyj
Finland
0.86 %
-
17. Commerzbank AG
Germany
0.83 %
-

The list of fund holdings was last updated on July 25, 2025.